Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.37 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.32 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.32 |
| ▸ | CASR | P41180 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL598363 | 0.84 | NOS3 (0.56) | NOS3NOS1NOS2TDP1SLC7A5 | |
| SCHEMBL770416 | 0.84 | NOS3 (0.56) | NOS3NOS1NOS2TDP1SLC7A5 | |
| SCHEMBL9980878 | 0.84 | NOS3 (0.56) | NOS3NOS1NOS2TDP1SLC7A5 | |
| SCHEMBL770417 | 0.84 | NOS3 (0.56) | NOS3NOS1NOS2TDP1SLC7A5 | |
| SCHEMBL678145 | 0.84 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1TSHR | |
| SCHEMBL3449733 | 0.84 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1TSHR | |
| SCHEMBL678144 | 0.84 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1TSHR | |
| Hydrochloric Acid SCHEMBL7592766 | 0.82 | NOS1 (0.55) | NOS3NOS1NOS2TDP1SLC7A5 | |
| Hydrogen Sulfide SCHEMBL22463012 | 0.82 | NOS3 (0.55) | NOS3NOS1NOS2TDP1SLC7A5 | |
| Hydrochloric Acid SCHEMBL19209653 | 0.82 | NOS1 (0.55) | NOS3NOS1NOS2TDP1SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110312890-A1 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS | SIGNATURE R&D HOLDINGS, LLC (US) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312890-A1 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS | PLTP, GP6, PDGFA | NOS3 414/4885NOS1 849/4885NOS2 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.